Methylthioninium Chloride News
Methylthioninium Chloride currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Methylthioninium Chloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
- Evidence level: L5
- Predicted indications (20):
- irritable bowel syndrome (90.4%)
- dysthymic disorder (88.5%)
- anaphylaxis (88.1%)
- food-dependent exercise-induced anaphylaxis (87.8%)
- bronchitis (85.5%)
- anxiety (80.6%)
- obsolete rare pulmonary disease (75.2%)
- variably protease-sensitive prionopathy (74.8%)
- autonomic nervous system disease (74.5%)
- pulmonary edema (73.9%)
- pityriasis simplex (73.5%)
- multiple system atrophy (72.8%)
- cauda equina syndrome (71.0%)
- primary hereditary glaucoma (69.9%)
- acrodermatitis chronica atrophicans (67.8%)
- dermatitis (67.1%)
- obsolete neurogenic bladder (disease) (66.7%)
- neurocirculatory asthenia (65.8%)
- open-angle glaucoma (65.7%)
- benign paroxysmal torticollis of infancy (65.5%)
Related News (1)
Vous êtes fatigué en ce début d’automne ? C’est normal mais vous pouvez y remédier - Le HuffPost
2026-10-10 EPOC
Source: Le HuffPost
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.